Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mendelics | RCV000990794 | SCV001141833 | pathogenic | Intellectual disability, X-linked 102 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
| Broad Center for Mendelian Genomics, |
RCV000990794 | SCV003922292 | likely pathogenic | Intellectual disability, X-linked 102 | 2023-05-02 | criteria provided, single submitter | curation | The heterozygous p.Ser58Ter variant in DDX3X was identified by our study in one individual with microcephaly, hypotonia, intellectual disability, developmental delays, and autism. Trio exome analysis showed this variant to be de novo. The p.Ser58Ter variant in DDX3X has been previously reported in one individual with X-linked DDX3X-related neurodevelopmental disorder (PMID: 30349862). The number of reported affected individuals with this variant is slightly greater than expected compared to non-affected individuals with this variant. This variant is assumed de novo in this individual, but paternity and maternity have not been confirmed (PMID: 30349862). This variant has also been reported in ClinVar (Variation ID: 803981) and has been interpreted as pathogenic by Mendelics. This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 58, which is predicted to lead to a truncated or absent protein. Loss of function of the DDX3X gene is strongly associated to X-linked DDX3X-related neurodevelopmental disorder. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for X-linked DDX3X-related neurodevelopmental disorder. ACMG/AMP Criteria applied: PVS1_Strong, PS2_Moderate, PS4_Supporting, PM2_Supporting, PM6_Supporting (Richards 2015). |